ID

34603

Beschrijving

Performance of a Tablet Based Workflow and Decision Support System With Incorporated Software Algorithm Used for Glycaemic Management; ODM derived from: https://clinicaltrials.gov/show/NCT01766752

Link

https://clinicaltrials.gov/show/NCT01766752

Trefwoorden

Versies (3)
  1. 19-01-19 19-01-19 -
  2. 17-04-20 17-04-20 -
  3. 17-04-20 17-04-20 - Sarah Riepenhausen
Houder van rechten

see on clinicaltrials.gov

Geüploaded op

19 januari 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

  • Nieuwste
  • Oudste
  • Populair
  • Nieuwste
    • Nieuwste
    • Oudste
    • Populair

Geen commentaren

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Type 2 Diabetes NCT01766752

Engels

Eligibility Type 2 Diabetes NCT01766752

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
informed consent obtained after being advised of the nature of the study
Beschrijving

ID.1

Datatype

boolean

male or female aged 18 - 90 years (both inclusive)
Beschrijving

ID.2

Datatype

boolean

type 2 diabetes treated with diet, oral agents, non-insulin injected anti-diabetic medicine, insulin therapy or any combination of the four
Beschrijving

ID.3

Datatype

boolean

Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
impaired renal function (serum creatinine ≥3.0mg/dl)
Beschrijving

ID.4

Datatype

boolean

any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the patient
Beschrijving

ID.5

Datatype

boolean

pregnancy
Beschrijving

ID.6

Datatype

boolean

any mental condition rendering the patient incapable of giving his consent
Beschrijving

ID.7

Datatype

boolean

terminally ill patients
Beschrijving

ID.8

Datatype

boolean

participation in a trial within 3 months prior to this trial
Beschrijving

ID.9

Datatype

boolean

known or suspected allergy to insulin
Beschrijving

ID.10

Datatype

boolean

Terug naar het begin van de pagina

Similar models

Eligibility Type 2 Diabetes NCT01766752

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
informed consent obtained after being advised of the nature of the study
boolean
ID.2
Item
male or female aged 18 - 90 years (both inclusive)
boolean
ID.3
Item
type 2 diabetes treated with diet, oral agents, non-insulin injected anti-diabetic medicine, insulin therapy or any combination of the four
boolean
Item Group
C0680251 (UMLS CUI)
ID.4
Item
impaired renal function (serum creatinine ≥3.0mg/dl)
boolean
ID.5
Item
any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the patient
boolean
ID.6
Item
pregnancy
boolean
ID.7
Item
any mental condition rendering the patient incapable of giving his consent
boolean
ID.8
Item
terminally ill patients
boolean
ID.9
Item
participation in a trial within 3 months prior to this trial
boolean
ID.10
Item
known or suspected allergy to insulin
boolean
Terug naar het begin van de pagina 

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial